Archive - March 2018
MHRA authorises in vivo genome editing trial
FDA turns away filing for Celgene’s MS drug
Cell and Gene Therapy Catapult forges stronger link with Japan
GP satisfaction hits all time low
NICE nod for Merck/Pfizer’s Bavencio
Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis
What’s The Science Behind Caffeine Withdrawal?
Sudden Temperature Changes May Lead To Heart Attacks